论文部分内容阅读
目的探讨研究诺和龙联合二甲双胍治疗初诊2型糖尿病临床疗效。方法我院2005年12月至2008年10月期间门诊或住院的初诊2型糖尿病患者124例,随机分为联合治疗组62例和对照组62例并进行临床指标观察。结果经过统计学比较分析两组观察指标治疗前与治疗后比较P<0.05,有显著差异性。两组治疗后观察指标比较P<0.05,有显著差异性。结论通过本组病例观察,诺和龙联和二甲双胍治疗临床疗效明显优于单用二甲双胍,毒副作用少,应用方便,疗效可靠。
Objective To investigate the clinical effect of Novolinon combined with metformin in the treatment of newly diagnosed type 2 diabetes. Methods A total of 124 newly diagnosed type 2 diabetic patients in our hospital from December 2005 to October 2008 were randomly divided into the treatment group (62 cases) and the control group (62 cases). The clinical indexes were observed. Results After statistical analysis of two groups of observed indicators before and after treatment compared P <0.05, significant difference. The two groups after treatment compared with the observed indicators P <0.05, significant difference. Conclusion Through the observation of this group of patients, the clinical efficacy of Novolinon and metformin is obviously superior to that of metformin alone, with less side effects, convenient application and reliable curative effect.